Glucagon-Like Peptide Analogs Are Superior for Diabetes and Weight Control in Patients on Antipsychotic Medications

医学 减肥 内科学 抗抑郁药 糖尿病 抗精神病药 不利影响 内分泌学 肥胖 精神分裂症(面向对象编程) 精神科 海马体
作者
Lauren Perlis,J. Steven Lamberti,Susanne U. Miedlich
出处
期刊:The primary care companion for CNS disorders [Physicians Postgraduate Press, Inc.]
卷期号:22 (1) 被引量:4
标识
DOI:10.4088/pcc.19m02504
摘要

Glucagon-like peptide (GLP-1) analogs promote diabetes control and weight loss. Most GLP-1 analogs also lower adverse cardiovascular outcomes, making them ideal agents for patients with severe mental illness. The objective of this study was to analyze diabetic patients taking antipsychotic medications, comparing those on GLP-1 analogs with those on other diabetes treatments.A total of 46 patients referred to outpatient diabetes clinics between July 2010 and April 2017 who were prescribed antipsychotic medications during the entire study period were included in this retrospective analysis. Eleven (24%) patients were started on a GLP-1 analog (cases), and 35 (76%) were treated with alternative antidiabetic agents (controls).Cases and controls did not differ in age, sex, height, weight, or medical therapies at the time of referral. Within 1 year, a reduction in mean ± SE glycosylated hemoglobin (HbA1c) levels was noted for both groups (cases: -1.26% ± 0.17%, controls: -1.47% ± 0.45%). However, while patients on GLP-1 analogs lost 7.07 ± 2.62 kg, control patients gained 1.93 ± 1.14 kg (P < .05). Blunted HbA1c reductions were also noted in patients who took antipsychotic medication in addition to antidepressant medication (on antidepressant medication [n = 22]: -0.77% ± 0.29%, off antidepressant medication [n = 9]: -2.97% ± 0.6%, P < .001). This observation did not apply to patients treated with GLP-1 analogs, as they had larger HbA1c reductions than patients on alternative regimens (controls [n = 15]: -0.46% ± 0.4%, cases [n = 7]: -1.43% ± 0.15%, P < .05).GLP-1 analogs promote both diabetes and weight control in diabetic patients on antipsychotic medications with or without antidepressant medications.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Ray完成签到 ,获得积分10
刚刚
文静的天蓝完成签到,获得积分10
刚刚
tszjw168完成签到 ,获得积分10
1秒前
手打鱼丸完成签到 ,获得积分10
2秒前
体贴凌柏发布了新的文献求助10
2秒前
开心快乐发大财完成签到,获得积分10
4秒前
萌萌哒完成签到,获得积分10
4秒前
小龅牙吖完成签到,获得积分10
4秒前
Propitious完成签到,获得积分10
5秒前
徐先生1106完成签到,获得积分10
5秒前
Epiphany完成签到,获得积分10
6秒前
舒心的久完成签到 ,获得积分10
6秒前
闻巷雨完成签到 ,获得积分10
8秒前
北风完成签到,获得积分10
9秒前
xliiii完成签到,获得积分10
9秒前
时光倒流的鱼完成签到,获得积分10
10秒前
LL完成签到,获得积分10
10秒前
李李完成签到,获得积分20
10秒前
雨无意完成签到,获得积分10
11秒前
盛宇大天才完成签到,获得积分10
13秒前
游戏人间完成签到 ,获得积分10
14秒前
15秒前
科研通AI5应助淡淡的忆彤采纳,获得10
15秒前
早日毕业完成签到,获得积分10
15秒前
Billie完成签到,获得积分10
16秒前
积极行天完成签到,获得积分10
16秒前
98完成签到,获得积分10
17秒前
nkmenghan完成签到,获得积分20
18秒前
韶邑完成签到,获得积分10
18秒前
penzer完成签到 ,获得积分10
19秒前
suwan完成签到,获得积分10
20秒前
张瀚文完成签到 ,获得积分10
23秒前
不吃香菜完成签到 ,获得积分10
25秒前
何日完成签到,获得积分10
27秒前
明天完成签到,获得积分10
27秒前
rrrick完成签到,获得积分10
27秒前
XF发布了新的文献求助10
28秒前
结实乐曲完成签到,获得积分10
28秒前
28秒前
29秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038303
求助须知:如何正确求助?哪些是违规求助? 3576013
关于积分的说明 11374210
捐赠科研通 3305780
什么是DOI,文献DOI怎么找? 1819322
邀请新用户注册赠送积分活动 892672
科研通“疑难数据库(出版商)”最低求助积分说明 815029